James Linder MD

James Linder MD has a long and varied career in the medical field. James began their career in 1983 as a Professor of Pathology and Microbiology at the University of Nebraska Medical Center. In 1995, they joined Cytyc as Senior Vice President and/or Chief Medical Officer, where they helped transform women's health. In 2009, they joined Constitution Medical Investors as Chief Medical Officer, where they developed a method to determine the complete blood count. In 2011, they became Founder of Tethon 3D and Founder and Managing Director of Linseed Capital LLC. James also served as Chief Strategist for the University of Nebraska from 2011-2017, and President of the University Technology Developers Corporation from 2011-2013. In 2017, they became Board Chair of the Nebraska Applied Research Institute, and in 2018 they became Chief Executive Officer of Nebraska Medicine.

James Linder MD completed their Doctor of Medicine (M.D.) at the University of Nebraska Medical Center between 1977 and 1980. James then completed their Residency in Pathology at Duke University between 1980 and 1982.